Loading...

Sana Biotechnology, Inc.

SANA•NASDAQ
Healthcare
Biotechnology
$3.40
$0.19(5.76%)
U.S. Market is Open • 12:28

Sana Biotechnology, Inc. (SANA) Stock Overview

Explore Sana Biotechnology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap928.7M
P/E Ratio-3.62
EPS (TTM)$-0.93
ROE-1.42%
Fundamental Analysis

AI Price Forecasts

1 Month$3.73
3 Months$3.67
1 Year Target$1.96

SANA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sana Biotechnology, Inc. (SANA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.28, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.62 and a market capitalization of 928.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
8.41%
5-Day Change
10.13%
1-Month Change
3.57%
3-Month Change
-26.58%
6-Month Change
-21.80%
Year-to-Date (YTD) Change
-14.50%
1-Year Change
92.27%
3-Year Change
-32.95%
5-Year Change
-86.10%
All-Time (Max) Change
-90.09%

Contact Information

https://www.sana.com
206 701 7914
188 East Blaine Street, Seattle, WA, 98102

Company Facts

194 Employees
IPO DateFeb 4, 2021
CountryUS
Actively Trading

Frequently Asked Questions